Citation: | SHAN Na, ZHAO Li, LIN Xiaodong. Predictive value of serum matrix metalloproteinase-9 and neurofilament light chain levels for cognitive impairment patients after first-onset ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2023, 27(8): 67-70, 90. DOI: 10.7619/jcmp.20230606 |
To investigate the predictive value of serum matrix metalloproteinase-9 (MMP-9) and neurofilament light chain (NFL) for post-stroke cognitive impairment (PSCI) in patients with first-onset acute ischemic stroke (AIS).
Eighty patients with AIS were selected. According to Montreal Cognitive Assessment (MoCA) score after 6 months of stroke, they were divided into PSCI group (MoCA score < 26) and non-PSCI group (MoCA score ≥26). The serum levels of MMP-9 and NFL were compared between the two groups on admission; the correlations of MMP-9 and NFL level with MoCA score were analyzed; the Logistic regression model was used to determine the risk factors of PSCI; the receiver operating characteristic (ROC) curve was used to evaluate the predictive efficacy of MMP-9 and NFL levels on PSCI.
The serum levels of MMP-9 and NFL in the PSCI group were significantly higher than those in the non-PSCI group (P < 0.05). Pearson correlation analysis showed that MMP-9 and NFL levels at admission were negatively correlated with MoCA scores 6 months after discharge (r=-0.457, -0.512; P < 0.05). Logistic regression analysis showed that age (OR=1.468), MMP-9 level (OR=1.694) and NFL level (OR=1.802) were independent influencing factors for PSCI in patients with first-ever AIS (P < 0.05). ROC curve analysis showed that the area under the curve (AUC) of MMP-9 and NFL level predicting the occurrence of PSCI at admission were 0.805 and 0.833, respectively; the AUC predicted by the combination of the two indexes was 0.905, which was higher than that of a single index, and the difference was statistically significant (P < 0.05).
Both MMP-9 and NFL can be used as predictors of PSCI occurrence in patients with first-onset AIS, and their combined evaluation can further improve the predictive efficacy.
[1] |
汪凯, 董强. 卒中后认知障碍管理专家共识2021[J]. 中国卒中杂志, 2021, 16(4): 376-389. doi: 10.3969/j.issn.1673-5765.2021.04.011
|
[2] |
LI J, WANG J, WU B, et al. Association between early cognitive impairment and midterm functional outcomes among Chinese acute ischemic stroke patients: a longitudinal study[J]. Front Neurol, 2020, 11: 20. doi: 10.3389/fneur.2020.00020
|
[3] |
OBAID M, FLACH C, MARSHALL I, et al. Long-term outcomes in stroke patients with cognitive impairment: a population-based study[J]. Geriatrics (Basel), 2020, 5(2): 32. doi: 10.3390/geriatrics5020032
|
[4] |
ZHONG C K, BU X Q, XU T, et al. Serum matrix metalloproteinase-9 and cognitive impairment after acute ischemic stroke[J]. J Am Heart Assoc, 2018, 7(1): e007776. doi: 10.1161/JAHA.117.007776
|
[5] |
UPHAUS T, BITTNER S, GR?SCHEL S, et al. NfL (neurofilament light chain) levels as a predictive marker for long-term outcome after ischemic stroke[J]. Stroke, 2019, 50(11): 3077-3084. doi: 10.1161/STROKEAHA.119.026410
|
[6] |
张颖, 张春丽, 李璐, 等. 血管性痴呆患者血清MMP-9, NLRP3, Hcy水平变化及其与认知、神经功能、预后的关系[J]. 卒中与神经疾病, 2021, 28(1): 67-72. doi: 10.3969/j.issn.1007-0478.2021.01.014
|
[7] |
张雪卫, 傅强. 脑脊液中β淀粉样蛋白42和神经丝轻链蛋白水平与术后神经认知功能障碍的相关性: 基于90例66~78岁患者[J]. 南方医科大学学报, 2021, 41(4): 574-578.
|
[8] |
O′DRISCOLL C, SHAIKH M. Cross-cultural applicability of the Montreal cognitive assessment (MoCA): a systematic review[J]. J Alzheimers Dis, 2017, 58(3): 789-801. doi: 10.3233/JAD-161042
|
[9] |
王安安, 李文娟. 脑卒中后认知功能障碍的中医治疗研究进展[J]. 中西医结合心脑血管病杂志, 2022, 20(14): 2565-2568.
|
[10] |
ZHU Z B, ZHONG C K, GUO D X, et al. Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure[J]. Atherosclerosis, 2019, 287: 30-37. doi: 10.1016/j.atherosclerosis.2019.05.028
|
[11] |
ZHANG X X, BI X. Post-stroke cognitive impairment: a review focusing on molecular biomarkers[J]. J Mol Neurosci, 2020, 70(8): 1244-1254. doi: 10.1007/s12031-020-01533-8
|
[12] |
刘梦珂, 郭潇潇, 职玲云, 等. CDDO-Im对缺血性脑卒中大鼠神经功能损伤修复的影响[J]. 中国病理生理杂志, 2022, 38(4): 651-657
|
[13] |
ZHONG C K, YANG J Y, XU T, et al. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke[J]. Neurology, 2017, 89(8): 805-812. doi: 10.1212/WNL.0000000000004257
|
[14] |
WEEKMAN E M, WILCOCK D M. Matrix metalloproteinase in blood-brain barrier breakdown in dementia[J]. J Alzheimers Dis, 2016, 49(4): 893-903. doi: 10.3233/JAD-150759
|
[15] |
张冬, 解战兵. 高原地区缺血性脑卒中患者血清基质金属蛋白酶-9、低氧诱导因子-1α表达及临床意义[J]. 国际神经病学神经外科学杂志, 2020, 47(3): 277-281.
|
[16] |
BORGWARDT L, DANIELSEN E R, THOMSEN C, et al. Alpha-mannosidosis: characterization of CNS pathology and correlation between CNS pathology and cognitive function[J]. Clin Genet, 2016, 89(4): 489-494. doi: 10.1111/cge.12642
|
[17] |
麦尔哈巴·赛里木, 郭晨晨, 张清瑜, 等. 神经丝轻链蛋白在阿尔茨海默病早期诊断中的作用研究[J]. 重庆医科大学学报, 2021, 46(11): 1355-1359.
|
[18] |
陈晨晖, 程楠, 向常清, 等. 急性缺血性脑卒中患者血清神经丝蛋白轻链、泛素羧基末端水解酶L1表达及其预后相关性[J]. 国际检验医学杂志, 2021, 42(18): 2195-2199.
|
[19] |
TIEDT S, DUERING M, BARRO C, et al. Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke[J]. Neurology, 2018, 91(14): e1338-e1347.
|
[20] |
PEDERSEN A, STANNE T M, NILSSON S, et al. Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction[J]. J Neurol, 2019, 266(11): 2796-2806.
|
[21] |
张君琴, 张国新, 张振涛. 急性缺血性脑卒中后认知障碍的危险因素分析[J]. 中风与神经疾病杂志, 2021, 38(1): 32-35.
|
[22] |
汤爱洁, 戴秀娟, 胡鑫淼, 等. 缺血性脑卒中后3~6个月认知障碍影响因素的Meta分析[J]. 中国全科医学, 2022, 25(24): 3049-3056, 3064.
|
1. |
杨可非,刘文靖,周新尧,姜泉. 基于“体脏合痹”理论探讨干燥综合征病机论治. 中国中医基础医学杂志. 2025(02): 236-240 .
![]() | |
2. |
邹怡萌,邹纯朴,陈晓,朱杨壮壮,苏琳,胥孜杭. 基于“肺主皮毛”理论的中西联系与思考. 北京中医药大学学报. 2024(01): 42-48 .
![]() | |
3. |
张盈,杨波,蔡新利,王霜,王迎春. 干燥综合征患者血清HMGB1、Progranulin与NK细胞亚群和间质性肺疾病的关系研究. 现代生物医学进展. 2024(20): 3867-3869 .
![]() | |
4. |
陈嘉琪,杨建英,吴子华,张丽宁,张燕,胡琪,贺倩,黄子玮,余新波,罗静,陶庆文. 原发性干燥综合征合并间质性肺病的中医证候特点及相关因素分析. 中国实验方剂学杂志. 2023(08): 66-72 .
![]() | |
5. |
彭艳茹,闫世艳,罗成,张宁,李睿,王玉光. 中医药联合西医治疗干燥综合征相关间质性肺疾病的临床疗效和安全性的系统评价. 中国医院用药评价与分析. 2023(08): 980-984 .
![]() | |
6. |
王菲,时美红. 原发性干燥综合征患者唇腺组织中BTB/POZ结构域蛋白7及基质金属蛋白酶-9的表达与自身抗体的关系. 实用临床医药杂志. 2022(21): 98-102 .
![]() |